Korro Bio, Inc.KRRONASDAQ
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-34.29%
↓ 681% below average
Average (24q)
5.91%
Historical baseline
Range
High:35.28%
Low:-34.29%
Volatility
1177.9%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -34.29% |
| Q2 2025 | 6.55% |
| Q1 2025 | 16.37% |
| Q4 2024 | 6.25% |
| Q3 2024 | -6.85% |
| Q2 2024 | 26.27% |
| Q1 2024 | -12.00% |
| Q4 2023 | 17.82% |
| Q3 2023 | 7.20% |
| Q2 2023 | -12.06% |
| Q1 2023 | 35.28% |
| Q4 2022 | -9.35% |
| Q3 2022 | 28.52% |
| Q2 2022 | -33.97% |
| Q1 2022 | 8.45% |
| Q4 2021 | -19.13% |
| Q3 2021 | -10.41% |
| Q2 2021 | 14.54% |
| Q1 2021 | 28.45% |
| Q4 2020 | 16.02% |
| Q3 2020 | 15.49% |
| Q2 2020 | 31.47% |
| Q1 2020 | 8.03% |
| Q4 2019 | 18.99% |
| Q3 2019 | 0.00% |